Donghui Huang

Acquired Resistance to Crizotinib from a Mutation in <i>CD74</i>–<i>ROS1</i>

Mark M. Awad, Ryohei Katayama, Michele McTigue et al. · New England Journal of Medicine · 2013 · 408 citations · Full text

Genome Instability, Same Resistance Mutation, Oncogenic Agent +14

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non–Small-Cell Lung Cancer

Justin F. Gainor, Diane Tseng, Satoshi Yoda et al. · JCO Precision Oncology · 2017 · 255 citations

Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer’s disease

Dongdong Sun, Nuan Li, Weiwei Zhang et al. · Colloids and Surfaces B Biointerfaces · 2016 · 194 citations

Plga-functionalized Quercetin Nanoparticles, Neurodegenerative Diseases, Alzheimer's Disease +7

<i>In Vitro</i> and <i>In Vivo</i> Activity of Cabozantinib (XL184), an Inhibitor of RET, MET, and VEGFR2, in a Model of Medullary Thyroid Cancer

Frauke Bentzien, Marcus Zuzow, Nathan Heald et al. · Thyroid · 2013 · 129 citations · Full text

A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer

Maruja E. Lira, Yoon‐La Choi, Sun Min Lim et al. · Journal of Molecular Diagnostics · 2014 · 109 citations · Full text

Cancer Detection, Medicine, Single-tube Multiplexed Assay +11